Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
SOAs
SOAs
18/02/2020
Statement of Advice (SOA): bosentan (Tracleer) 67
18/02/2020
Statement of Advice (SOA): budesonide (Entocort CR) 3614
18/02/2020
Statement of Advice (SOA): Buprenorphine naloxone (Zubsolv) 3386
18/02/2020
Statement of Advice (SOA): busulfan (Busilvex) 2547
18/02/2020
Statement of Advice (SOA): c1-esterase inhibitor (Berinert) 2315
18/02/2020
Statement of Advice (SOA): c1-esterase inhibitor (Berinert) 2165
18/02/2020
Statement of Advice (SOA): zolpidemtartrate (Edluar) 1942
18/02/2020
Statement of Advice (SOA): zonisamide (Zonegran) 996
18/02/2020
Statement of Advice (SOA): zonisamide (Zonegran) 997
18/02/2020
Statement of Advice (SOA): voriconazole (Vfend) 1528
18/02/2020
Statement of Advice (SOA): canakinumab (Ilaris) 2093
18/02/2020
Statement of Advice (SOA): canakinumab (Ilaris) 1209
18/02/2020
Statement of Advice (SOA): canakinumab (Ilaris) 1210
18/02/2020
Statement of Advice (SOA): canakinumab (Ilaris) 1208
18/02/2020
Statement of Advice (SOA): canakinumab (Ilaris) 591
18/02/2020
Statement of Advice (SOA): vorapaxar (Zontivity) 1034
18/02/2020
Statement of Advice (SOA): vildagliptin metformin hydrochloride (Eucreas) 1930
18/02/2020
Statement of Advice (SOA): vildagliptin (Galvus) 1529
18/02/2020
Statement of Advice (SOA): vernakalant (Brinavess) 572
18/02/2020
Statement of Advice (SOA): Vandetanib (Caprelsa) 3349
1
2
3
4
5
6
7
8
9
10
11
Follow AWTTC: